Delivery Order SPE2DB22D2206-SPE2DB25FGS20
- Not listed
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in cancer treatment. This competitive, non-set-aside contract was awarded on June 3, 2025, with an ultimate completion date of June 25, 2025, and represents a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,827.40, is for the supply of TIBSOVO 250 MG TABLET 60S, a specialty pharmaceutical product. The contract has a period of performance through March 14, 2025, and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,827.40, is for the supply of TIBSOVO 250 MG Tablets and has a period of performance ending on February 14, 2025. The contract does not have a set-aside designation, indicating that it was open to competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $19,882.84 firm fixed price delivery order is for the supply of TIBSOVO 250 MG tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- The Defense Logistics Agency Troop Support Medical awarded a $19,482 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 60 tablets of 250 mg TIBSOVO, an oncology medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 15, 2023. DLA Troop Support Medical supports the Department of Defense healthcare system through its management of the Federal Supply Schedule program and related contracting vehicles. This...
- <p>The Defense Logistics Agency awarded a $19,482 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561706899 TIBSOVO 250 MG TABLET 60S. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 in support of DLA programs. Amerisourcebergen will perform under the contract without a designated set aside. No subcontractors or additional context were provided regarding the agency's use of the products.</p>
- The federal contract award is for the delivery order SPE2DB22D3501|SPE2DB25FTW25, valued at $20,570.02, to supply the pharmaceutical product TIBSOVO 250 MG TABLET 60S. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a comprehensive range of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $20,496.38 to AmerisourceBergen Drug Corp for Ibtrozi 200 mg capsules (30-count supply) on September 3, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGS20Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime pharmaceutical contract vehicle enables AmerisourceBergen to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies. The company's selection reflects its established capability to meet federal procurement requirements for critical pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 4/23/25 |